Competitive nicotinic acetylcholine receptor antagonist with moderate selectivity for the neuronal α
4 receptor subunit (IC50
values are 0.19 and 0.37 μ
M for α
4 and α
2 receptors respectively). Antagonizes behavioral effects of nicotine in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Binding of the nicotinic cholinergic antagonist, dihydro-β-erythroidine, to rat brain tissue.
Williams and Robinson
In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice.
Damaj et al.
Multiple determinants of dihydro-β-erythroidine sensitivity on rat neuronal nicotinic receptor #945; subunits.
Harvey et al.
The citations listed below are publications that use Tocris products. Selected citations for Dihydro-β-erythroidine hydrobromide include:
Showing Results 1 - 10 of 17